Literature DB >> 16024625

The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program.

Bram De Craene1, Barbara Gilbert, Christophe Stove, Erik Bruyneel, Frans van Roy, Geert Berx.   

Abstract

Abberant activation of the process of epithelial-mesenchymal transition in cancer cells is a late event in tumor progression. A key inducer of this transition is the transcription factor Snail, which represses E-cadherin. We report that conditional expression of the human transcriptional repressor Snail in colorectal cancer cells induces an epithelial dedifferentiation program that coincides with a drastic change in cell morphology. Snail target genes control the establishment of several junctional complexes, intermediate filament networks, and the actin cytoskeleton. Modulation of the expression of these genes is associated with loss of cell aggregation and induction of invasion. Chromatin immunoprecipitation experiments showed that repression of selected target genes is associated with increased binding of Snail to their promoters, which contain consensus Snail-binding sites. Thus, Snail constitutes a master switch that directly represses the epithelial phenotype, resulting in malignant carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16024625     DOI: 10.1158/0008-5472.CAN-04-3545

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  93 in total

1.  Cancer cells regulate biomechanical properties of human microvascular endothelial cells.

Authors:  Claudia Tanja Mierke
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

2.  14-3-3 binding sites in the snail protein are essential for snail-mediated transcriptional repression and epithelial-mesenchymal differentiation.

Authors:  Zhaoyuan Hou; Hongzhuang Peng; David E White; Pu Wang; Paul M Lieberman; Thanos Halazonetis; Frank J Rauscher
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

Review 3.  The skinny on Slug.

Authors:  Stephanie H Shirley; Laurie G Hudson; Jing He; Donna F Kusewitt
Journal:  Mol Carcinog       Date:  2010-10       Impact factor: 4.784

Review 4.  Tumour budding in colorectal cancer: what do we know and what can we do?

Authors:  Linde De Smedt; Sofie Palmans; Xavier Sagaert
Journal:  Virchows Arch       Date:  2015-11-27       Impact factor: 4.064

5.  Negative Regulatory Role of TWIST1 on SNAIL Gene Expression.

Authors:  Mohammad Mahdi Forghanifard; Sima Ardalan Khales; Moein Farshchian; Abolfazl Rad; Masoud Homayouni-Tabrizi; Mohammad Reza Abbaszadegan
Journal:  Pathol Oncol Res       Date:  2016-07-20       Impact factor: 3.201

6.  Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer.

Authors:  Jennifer L Yori; Darcie D Seachrist; Emhonta Johnson; Kristen L Lozada; Fadi W Abdul-Karim; Lewis A Chodosh; William P Schiemann; Ruth A Keri
Journal:  Neoplasia       Date:  2011-07       Impact factor: 5.715

7.  Promoter-independent regulation of vimentin expression in mammary epithelial cells by val(12)ras and TGFbeta.

Authors:  Bradley Yates; Craig Zetterberg; Vaishali Rajeev; Michael Reiss; Susan R Rittling
Journal:  Exp Cell Res       Date:  2007-08-01       Impact factor: 3.905

8.  The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha.

Authors:  Archana Dhasarathy; Masahiro Kajita; Paul A Wade
Journal:  Mol Endocrinol       Date:  2007-08-30

9.  ZEB-1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells.

Authors:  Jonathan Clarhaut; Robert M Gemmill; Vincent A Potiron; Slimane Ait-Si-Ali; Jean Imbert; Harry A Drabkin; Joëlle Roche
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

10.  An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance.

Authors:  Lauren Averett Byers; Lixia Diao; Jing Wang; Pierre Saintigny; Luc Girard; Michael Peyton; Li Shen; Youhong Fan; Uma Giri; Praveen K Tumula; Monique B Nilsson; Jayanthi Gudikote; Hai Tran; Robert J G Cardnell; David J Bearss; Steven L Warner; Jason M Foulks; Steven B Kanner; Varsha Gandhi; Nancy Krett; Steven T Rosen; Edward S Kim; Roy S Herbst; George R Blumenschein; J Jack Lee; Scott M Lippman; K Kian Ang; Gordon B Mills; Waun K Hong; John N Weinstein; Ignacio I Wistuba; Kevin R Coombes; John D Minna; John V Heymach
Journal:  Clin Cancer Res       Date:  2012-10-22       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.